GT BIOPHARMA, INC. — Revenue by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/0a1134e9-e5a5-45f6-97aa-a0fad2861b35/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2020 | $0 | 2020-01-01 – 2020-12-31 | evidence 0001654954-21-004295 |
| FY 2019 | $0 | 2019-01-01 – 2019-12-31 | evidence 0001654954-21-004295 |
| FY 2017 | $0 | 2017-01-01 – 2017-12-31 | evidence 0001654954-18-002054 |
| FY 2016 | $0 | 2016-01-01 – 2016-12-31 | evidence 0001654954-17-002919 |
| FY 2015 | $27.0k | 2015-01-01 – 2015-12-31 | evidence 0001354488-16-006816 |
| FY 2014 | $61.0k | 2014-01-01 – 2014-12-31 | evidence 0001513160-15-000022 |
| FY 2013 | $368.0k | 2013-01-01 – 2013-12-31 | evidence 0001513160-15-000005 |
| FY 2012 | $342.0k | 2012-01-01 – 2012-12-31 | evidence 0001513160-14-000064 |
| FY 2011 | $26.0k | 2011-01-01 – 2011-12-31 | evidence 0001513160-12-000030 |
| FY 2010 | $11.0k | 2010-01-01 – 2010-12-31 | evidence 0001513160-12-000030 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
GT BIOPHARMA, INC. — all facts · Net Income · Operating Income